Rethinking the Role of Radiation
Chest radiation may not be necessary for people with intermediate-risk breast cancer.
Progress Against Cancer
Chest radiation may not be necessary for people with intermediate-risk breast cancer.
Active surveillance of DCIS patients may be an alternative to treatment, and guidelines add self-test for HPV.
Research finds certain people with low-risk DCIS may be able to forgo surgery or radiation.
HPV vaccine credited for decrease in cervical cancer deaths among young women, and new technology extends survival in locally advanced pancreatic cancer.
Pancreatic cancer surge in younger people has not led to a rise in deaths, and researchers will study long-term survivors to better understand cancer responses.
The FDA granted accelerated approval to the first-in-class HER2-directed bispecific antibody zanidatamab-hrii. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to zanidatamab-hrii (Ziihera) for previously treated, unresectable or metastatic human epidermal...
The FDA Project Renewal initiative has updated the approved indications for fludarabine phosphate chemotherapy in chronic lymphocytic leukemia. The U.S. Food and Drug Administration (FDA) has approved updated labeling of fludarabine phosphate (Fludarabine Phosphate...
Using high-dose testosterone after prostate cancer stops responding to androgen deprivation therapy can stop tumor growth.
The FDA approved revumenib, a first-in-class menin inhibitor, to treat acute leukemias with a KMT2A translocation. The U.S. Food and Drug Administration (FDA) has approved revumenib (Revuforj) for the treatment of adult and pediatric...
Complications can affect men years after prostate cancer treatment, and many people eligible for lung cancer screening do not get it.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now